Efficacy of Roflumilast in the Treatment of Psoriasis
NCT04549870
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
46
Enrollment
OTHER
Sponsor class
Conditions
Psoriasis
Interventions
DRUG:
Roflumilast
Sponsor
Bispebjerg Hospital